Did patients experience a clinically meaningful improvement in symptoms?

At three months, 84.3% of patients treated with Lacrifill^® achieved a clinically important improvement in OSDI score, compared with 83.3% of patients receiving the hydrogel plug. Lacrifill^® met the predefined non-inferiority endpoint.²